<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Cardiac device implantations in obese patients: Success rates and complications</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">Philipp</forename><surname>Attanasio</surname></persName>
							<email>philipp.attanasio@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité University Hospital Berlin</orgName>
								<address>
									<addrLine>Campus Virchow-Klinikum</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Philipp</forename><surname>Lacour</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité University Hospital Berlin</orgName>
								<address>
									<addrLine>Campus Virchow-Klinikum</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Ernert</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Biometrics and Clinical Epidemiology</orgName>
								<orgName type="institution">Charité University Hospital Berlin</orgName>
								<address>
									<addrLine>Campus Virchow-Klinikum</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><surname>Burkert Pieske</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité University Hospital Berlin</orgName>
								<address>
									<addrLine>Campus Virchow-Klinikum</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">German Heart Center Berlin</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wilhelm</forename><surname>Haverkamp</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité University Hospital Berlin</orgName>
								<address>
									<addrLine>Campus Virchow-Klinikum</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Florian</forename><surname>Blaschke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité University Hospital Berlin</orgName>
								<address>
									<addrLine>Campus Virchow-Klinikum</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Francesco</forename><surname>Dalle Vedove</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Medicine, General Medicine and Hypertension</orgName>
								<orgName type="institution">University of Verona</orgName>
								<address>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Huemer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité University Hospital Berlin</orgName>
								<address>
									<addrLine>Campus Virchow-Klinikum</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité University Hospital Berlin</orgName>
								<address>
									<addrLine>Campus Virchow-Klinikum, Augustenburger Platz 1</addrLine>
									<postCode>13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Cardiac device implantations in obese patients: Success rates and complications</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">13CDCB089B17169B39AA852866A0E809</idno>
					<idno type="DOI">10.1002/clc.22650</idno>
					<note type="submission">Received: 3 August 2016 Revised: 28 October 2016 Accepted: 2 November 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:43+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Obesity</term>
					<term>Cardiac implantable electrical devices</term>
					<term>CIED</term>
					<term>complications</term>
					<term>radiation dose</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Obesity is associated with increased complications and potentially worse outcomes for various cardiac interventions.</s><s>This study analyzed the success rate and complication rates associated with implantation of cardiac implantable electronic devices (CIEDs) in obese patients.</s></p><p><s>Hypothesis: Success rates are lower and complication rates higher in obese patients.</s></p><p><s>Methods: Consecutive patients undergoing CIED implantation between 2011 and 2015 in our hospital were included.</s><s>Patients were categorized into obese and nonobese groups according to body mass index (BMI); cutoff was 30 kg/m 2 .</s><s>Patient characteristics, complication rates, procedural duration, and fluoroscopy data were compared between the 2 groups.</s></p><p><s>Results: A total of 965 patients (mean age, 69.0 AE 12.9 years; 67% male) were included.</s><s>Of these, 249 (25.8%) patients were classified obese and 716 (74.2%) nonobese.</s><s>Mean BMI was 34.7 AE 4.7 kg/m 2 vs 25.1 AE 3.0 kg/m 2 , respectively.</s><s>There was no difference in procedural success rates between the 2 groups (97.2% vs 97.1%, respectively).</s><s>Major complications were significantly lower in the obese group compared with the nonobese group (11 [4.4%] vs 62 [8.7%]; P &lt; 0.05).</s><s>Procedural duration and fluoroscopy duration were not different between the 2 groups, but the total dose-area product was significantly higher in obese patients vs nonobese patients (4012 AE 5416 cGcm 2 vs 2692 AE 5277 cGcm 2 ; P &lt; 0.005).</s></p><p><s>Conclusions: CIED implantation can be safely and effectively achieved in patients with BMI &gt;30 kg/m 2 .</s><s>However, total radiation dose was significantly higher in the obese group, emphasizing that efforts should be made to reduce radiation exposure in these patients.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>these devices in obese patients can be challenging.</s><s>Anesthesia can be difficult, mostly because of ventilation problems <ref type="bibr" target="#b4">5</ref> ; puncture of the subclavian or axillary vein is more difficult because neck landmarks can be obscured <ref type="bibr" target="#b5">6</ref> ; and visualization of lead placement can be impaired due to limited image quality, despite higher radiation doses. <ref type="bibr" target="#b6">7</ref></s><s> evaluate the safety and efficacy of various cardiac device implantations in obese patients, a retrospective analysis of 965 consecutive patients undergoing these procedures in the Charité University Hospital in Berlin, Germany, was performed.</s><s>The goal was to compare procedural success, complications, and total radiation dose needed for the implantation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">| METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">| Study design</head><p><s>This study is based on a retrospective chart review, approved by the institutional ethics committee, of 965 patients undergoing cardiac implantable electronic device (CIED) implantation in the Charité University Hospital in Berlin, Germany.</s><s>The procedures were performed between 2011 and 2015.</s></p><p><s>Patient demographics were obtained, including weight, height, relevant comorbidities, and fluoroscopy time.</s><s>Radiation dose was measured as dose-area product (DAP).</s><s>Procedure-related complications were recorded at the time of discharge and at the first follow-up visit 6 weeks after implantation.</s></p><p><s>Obesity was defined as a BMI &gt;30 kg/m 2 .</s><s>To maintain consistency regarding potential machine-related differences, reviewed procedures were performed in a single-catheter laboratory with the same x-ray system by the same 5 operators.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">| CIED implantations</head><p><s>Device implantations were performed after an evaluation by an electrophysiology expert and according to the indications of the current European Society of Cardiology guidelines. <ref type="bibr" target="#b7">8</ref></s><s>prophylactic dose of cefazolin was administered at the time of the procedure.</s><s>For periprocedural anesthesia, propofol and/or midazolam were used.</s><s>Oxygen (medium flow, 2 L/min) was administered via nasal cannula.</s><s>There was continuous monitoring of blood pressure, pulse oximetry, heart rate, and electrocardiography throughout the entire procedure, until the complete awakening of the patient.</s></p><p><s>The major approach for lead insertion was subclavian vein puncture (&gt;90%).</s><s>Axillary vein puncture or cephalic vein cut-down were used as alternative venous accesses.</s><s>Upon successful vein puncture or cut-down, a guidewire was inserted and positioned in the vena cava.</s><s>For the implantation of multiple leads, this procedure was repeated.</s><s>Lead insertion sheets were advanced over the wires.</s><s>Only active fixation leads were used.</s><s>Lead placement was performed under fluoroscopic guidance.</s><s>Right atrial leads were preferably placed anteriorly at the ostium of the right atrial appendage.</s><s>Right ventricular leads were preferably placed in the mid-septal region.</s><s>If a stable and effective lead position could not be achieved in the mid-septal region, right ventricular leads were placed in the apex of the right ventricle.</s></p><p><s>Left ventricular leads for biventricular stimulation were positioned basally in a lateral branch of the coronary sinus.</s></p><p><s>Pacing threshold, sensing, and impedance were recorded to ensure good placement.</s><s>A subcutaneous pocket was used for pacemaker insertion, whereas ICD or cardiac resynchronization therapy defibrillator (CRT-D) devices were placed submuscularly.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">| Definition of complications and follow-up</head><p><s>Routine chest radiography was performed 6 hours after the procedure to rule out pneumothorax, hemothorax, and lead dislodgement.</s><s>Device interrogation was again performed routinely 6 weeks after implantation.</s></p><p><s>According to severity and clinical relevance, complications were classified as major or minor.</s><s>Major complications included local infections requiring re-intervention, re-interventions within 6 weeks after implantation, major surgical-site bleeding, pneumothorax or pericardial effusion requiring drainage, implantation-related systemic infection or endocarditis, generator-lead connection problems or lead dislocation, and procedure-related death.</s><s>Surgical-site bleeding was classified as major in the following cases: the necessity of surgical re-intervention, a hemoglobin drop of &gt;3 g/dL, the necessity for blood transfusion, and a prolonged hospitalization.</s></p><p><s>Wound-healing disorders were defined as all cases of wound dehiscence or possible superficial infection, which were treated nonsurgically but required a prolonged phase of wound surveillance, delayed suture removal, or additional antibiotic treatment.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4">| Statistical analysis</head><p><s>For the description of patient baseline characteristics and procedural data, values are presented as absolute numbers and percentages for categorical variables or mean AE SD for continuous variables.</s><s>For comparison of categorical variables among obese and nonobese patients, χ 2 tests were used.</s><s>The independent sample t test was used to compare continuous variables.</s></p><p><s>For the comparison of procedure-related complications, additionally adjusted odds ratios (ORs) were calculated by using logistic regression models.</s><s>In all models, age, sex, type of device implantation, and left ventricular ejection fraction were used as covariables.</s><s>For major and minor bleeding and lead dislodgment, ORs were additionally adjusted for different types of anticoagulation.</s><s>For infections, ORs were additionally adjusted for diabetes mellitus.</s><s>For all tests, a level of significance of 5% was determined.</s></p><p><s>All analyses were performed using SPSS software version 22.0 (IBM Corp., Armonk, New York).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">| RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1">| Patient characteristics</head><p><s>The study included 965 patients.</s><s>A total of 249 patients (25.8%) were classified as obese and 716 patients (74.2%) were classified as nonobese.</s><s>Mean BMI was 25.1 AE 3.0 kg/m 2 vs 34.7 AE 4.7 kg/m 2 .</s><s>The mean age was 69.0 AE 12.9 years, with 67% being male patients.</s><s>Detailed characteristics of the studied population are shown in Table <ref type="table" target="#tab_0">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">| Success rates and complications</head><p><s>The analyzed procedures included 72 (7.4%) 1-chamber pacemaker implantations and 215 (22.2%) 1-chamber ICD implantations; 339 (35.1%) 2-chamber pacemaker implantations and 69 (7.1%) 2chamber ICD implantations; and 32 (3.3%) 3-chamber pacemaker implantations and 238 (26.4%)</s><s>CRT implantations.</s></p><p><s>The total procedure time (107.5 AE 72.4 minutes vs 97.4 AE 55.9 minutes; P = not significant) and overall success rates (97.2% vs 97.1%; P = not significant) were not significantly different between the 2 groups (Table <ref type="table" target="#tab_1">2</ref>).</s></p><p><s>The number of major complications was significantly lower in obese than nonobese patients (11 [4.4%] vs 62 [8.7%], P &lt; 0.05; OR: 2.2, 95% confidence interval: 1.1-4.4).</s><s>Further analysis according to the type of complications showed a significantly lower rate of major bleedings (1 [0.4%] vs 24 [3.4%],</s><s>P &lt; 0.05; OR: 10.4, 95% confidence interval: 1.3-80.2) and pneumothoraces (0 [0%] vs 13 [1.8%];</s><s>P &lt; 0.05) in obese patients (Table <ref type="table" target="#tab_2">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">| Radiation exposure</head><p><s>We observed a significantly higher DAP in obese patients compared with nonobese patients, whereas procedural duration and fluoroscopy time were not statistically different (Table <ref type="table" target="#tab_3">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4">| DISCUSSION</head><p><s>Obese patients represent a relevant proportion of patients undergoing cardiac device implantation.</s><s>In our study including consecutive patients in our hospital, &gt;25% of patients presented with a BMI &gt;30 kg/m 2 .</s></p><p><s>Two previous studies evaluated the potential influence of obesity on outcomes and complication rates of ICD and CRT implantations.</s><s>One smaller study including 58 patients with BMI &gt;30 kg/m 2 found no difference in procedural success rates and complication rates for ICD and CRT implantations in nonobese vs obese patients. <ref type="bibr" target="#b8">9</ref></s><s>The other study represents a subanalysis from the US National Cardiovascular Data Registry-ICD Registry.</s><s>In this analysis, obese patients also did not exhibit more complications compared with normal-weight patients, whereas being underweight was associated with a higher complication rate. <ref type="bibr" target="#b9">10</ref></s><s>r study including ICD, CRT-D, and pacemaker implantations not only confirms the finding that CIED implantation is safe and effective in obese patients, it seems that obesity may even have a protective effect on the development of pneumothorax and major bleeding.</s></p><p><s>Although it has been shown that a higher BMI is associated with a longer time taken for venous access and the use of more contrast, <ref type="bibr" target="#b10">11</ref> we found a lower rate of pneumothoraces in the obese patient group.</s><s>This was despite the fact that the obese patients in our study had a significantly higher rate of chronic obstructive lung disease, a well-known risk factor for the development of pneumothorax after CIED implantation. <ref type="bibr" target="#b11">12</ref></s><s>So even though surface landmarks are obscured in overweight patients, the larger distance from the surface of the skin to the lung due to subcutaneous fat seems to be protective.</s><s>This theory is supported by 2 cohort studies showing that the risk of pneumothorax after CIED implantation increased with decreasing BMI. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b12">13</ref></s><s>ditionally, obese patients in our study had fewer major bleedings compared with patients of normal weight.</s><s>Similar results, contradicting the working hypothesis that overweight and obese patients are at a higher risk of bleeding after cardiac interventions, were observed in 2 studies each including &gt;9000 patients undergoing percutaneous coronary intervention.</s><s>In both trials, patients with a BMI &gt;30 kg/m 2 had a significantly lower risk of bleeding compared with normal-weight patients. <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15</ref></s><s>Similar findings were observed after  Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HTN, hypertension; LVEF, left ventricular ejection fraction; NA, not available; NS, not significant; OAC, oral anticoagulation; OR, odds ratio.</s></p><p><s>1 All logistic regression models are adjusted for age, sex, type of device implanted, LVEF, DM, COPD, and HTN.</s></p><p><s>2 Additional adjustment for OAC, antiplatelet drugs, and renal failure.</s></p><p><s>3 None of the obese patients suffered the complication; therefore, an OR could not be calculated. <ref type="bibr" target="#b3">4</ref></s><s>Additional adjustment for renal failure and procedural duration. <ref type="bibr" target="#b4">5</ref></s><s>Any complication was adjusted for all of the above covariates.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE 1</head><label>1</label><figDesc><div><p><s>Patient baseline characteristics</s></p></div></figDesc><table><row><cell>Parameter</cell><cell>Total, N = 965</cell><cell>Obese Patients, n = 249</cell><cell>Nonobese Patients, n = 716</cell><cell>Significance</cell><cell>P Value</cell></row><row><cell>Age, y</cell><cell>69.2 AE 13.0</cell><cell>67.0 AE 10.8</cell><cell>69.9 AE 13.6</cell><cell>P &lt; 0.050</cell><cell>&lt;0.001</cell></row><row><cell>Height, cm</cell><cell>171.5 AE 9.5</cell><cell>171.9 AE 9.5</cell><cell>171.4 AE 9.5</cell><cell>NS</cell><cell>0.427</cell></row><row><cell>Weight, kg</cell><cell>81.4 AE 19</cell><cell>102.6 AE 17.9</cell><cell>74.0 AE 12.8</cell><cell>P &lt; 0.001</cell><cell>&lt;0.001</cell></row><row><cell>Male sex</cell><cell>649 (67.3)</cell><cell>171 (68.7)</cell><cell>478 (66.8)</cell><cell>NS</cell><cell>0.579</cell></row><row><cell>Arterial hypertension</cell><cell>766 (79.4)</cell><cell>217 (87.1)</cell><cell>549 (76.7)</cell><cell>P &lt; 0.001</cell><cell>&lt;0.001</cell></row><row><cell>Dilated cardiomyopathy</cell><cell>147 (15.3)</cell><cell>42 (17.0)</cell><cell>105 (14.8)</cell><cell>NS</cell><cell>0.401</cell></row><row><cell>AF</cell><cell>428 (44.4)</cell><cell>102 (41.0)</cell><cell>326 (45.6)</cell><cell>NS</cell><cell>0.205</cell></row><row><cell>CAD</cell><cell>510 (52.9)</cell><cell>136 (54.6)</cell><cell>374 (52.3)</cell><cell>NS</cell><cell>0.529</cell></row><row><cell>HF</cell><cell>579 (60.1)</cell><cell>163 (65.5)</cell><cell>416 (58.2)</cell><cell>P &lt; 0.050</cell><cell>0.043</cell></row><row><cell>NYHA class</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>0</cell><cell>2 (0.4)</cell><cell>2 (0.6)</cell><cell>0 (0.0)</cell><cell>NS</cell><cell>0.059</cell></row><row><cell>1</cell><cell>71 (14.3)</cell><cell>57 (16.3)</cell><cell>14 (9.5)</cell><cell></cell><cell></cell></row><row><cell>2</cell><cell>187 (37.6)</cell><cell>130 (37.1)</cell><cell>57 (38.5)</cell><cell></cell><cell></cell></row><row><cell>3</cell><cell>222 (44.6)</cell><cell>152 (43.4)</cell><cell>70 (47.3)</cell><cell></cell><cell></cell></row><row><cell>4</cell><cell>16 (3.2)</cell><cell>9 (2.6)</cell><cell>7 (4.7)</cell><cell></cell><cell></cell></row><row><cell>DM</cell><cell>299 (31.0)</cell><cell>102 (41.0)</cell><cell>197 (27.5)</cell><cell>P &lt; 0.001</cell><cell>&lt;0.001</cell></row><row><cell>COPD</cell><cell>143 (14.9)</cell><cell>47 (18.9)</cell><cell>96 (13.5)</cell><cell>P &lt; 0.050</cell><cell>0.039</cell></row><row><cell>CKD</cell><cell>401 (41.6)</cell><cell>112 (45.0)</cell><cell>289 (40.4)</cell><cell>NS</cell><cell>0.203</cell></row><row><cell>LVEF, %</cell><cell>41.2 AE 15.3</cell><cell>39.7 AE 14.8</cell><cell>41.8 AE 15.4</cell><cell>NS</cell><cell>0.050</cell></row><row><cell>OAC</cell><cell>477 (49.4)</cell><cell>117 (47.0)</cell><cell>360 (50.3)</cell><cell>NS</cell><cell>0.361</cell></row><row><cell>Antiplatelet therapy</cell><cell>556 (57.7)</cell><cell>156 (62.7)</cell><cell>400 (55.9)</cell><cell>NS</cell><cell>0.065</cell></row></table><note><p><s>Abbreviations: AF, atrial fibrillation; BMI, body mass index; CAD, coronary artery disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HF, heart failure; LVEF, left ventricular ejection fraction; NS, not significant; NYHA, New York Heart Association; OAC, oral anticoagulation; SD, standard deviation.</s><s>Data are presented as n (%) or mean AE SD.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>TABLE 2</head><label>2</label><figDesc><div><p><s>Procedural data</s></p></div></figDesc><table><row><cell>Procedure</cell><cell>Total, N = 965</cell><cell>Obese Patients, n = 249</cell><cell>Nonobese Patients, n = 716</cell><cell>Significance</cell></row><row><cell>Procedure duration, min, mean AE SD</cell><cell>100.0 AE 60.7</cell><cell>107.5 AE 72.4</cell><cell>97.4 AE 56.0</cell><cell>NS</cell></row><row><cell>Procedure success</cell><cell>939 (97.1)</cell><cell>242 (97.2)</cell><cell>697 (97.1)</cell><cell>NS</cell></row><row><cell>1-chamber pacemaker</cell><cell>72 (7.4)</cell><cell>19 (7.7)</cell><cell>53 (7.4)</cell><cell>NS</cell></row><row><cell>2-chamber pacemaker</cell><cell>339 (35.1)</cell><cell>81 (32.7)</cell><cell>258 (36)</cell><cell>NS</cell></row><row><cell>CRT-P</cell><cell>32 (3.3)</cell><cell>9 (3.6)</cell><cell>23 (3.2)</cell><cell>NS</cell></row><row><cell>1-chamber ICD</cell><cell>215 (22.2)</cell><cell>58 (23.4)</cell><cell>157 (21.9)</cell><cell>NS</cell></row><row><cell>2-chamber ICD</cell><cell>69 (7.1)</cell><cell>12 (4.8)</cell><cell>57 (7.9)</cell><cell>NS</cell></row><row><cell>CRT-D</cell><cell>238 (26.4)</cell><cell>69 (27.8)</cell><cell>169 (23.6)</cell><cell>NS</cell></row><row><cell>Implantation on the left side</cell><cell>845 (88.2)</cell><cell>215 (87)</cell><cell>630 (88.6)</cell><cell>NS</cell></row><row><cell>Subclavian vein puncture</cell><cell>918 (96.7)</cell><cell>238 (97.5)</cell><cell>680 (96.5)</cell><cell>NS</cell></row><row><cell cols="5">Abbreviations: CRT-D, cardiac resynchronization therapy defibrillator; CRT-P, cardiac resynchronization therapy pacemaker; ICD, implantable</cell></row><row><cell cols="2">cardioverter-defibrillator; NS, not significant; SD, standard deviation.</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Data are presented as n (%) unless otherwise noted.</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>TABLE 3</head><label>3</label><figDesc><div><p><s>Procedure-related complications</s></p></div></figDesc><table><row><cell></cell><cell>Total,</cell><cell>Obese Patients,</cell><cell>Nonobese</cell><cell>Significance,</cell><cell>Adjusted OR 1 (95% CI),</cell><cell></cell></row><row><cell>Complication</cell><cell>N (%)</cell><cell>n (%)</cell><cell>Patients, n (%)</cell><cell>χ 2</cell><cell>Nonobese vs Obese</cell><cell>Significance</cell></row><row><cell>Pocket hematoma</cell><cell>48 (5)</cell><cell>6 (2.4)</cell><cell>42 (5.9)</cell><cell>P &lt; 0.05</cell><cell>2.6 (1.0-6.3) 2</cell><cell>0.043</cell></row><row><cell>Minor bleeding</cell><cell>31 (3.2)</cell><cell>4 (1.6)</cell><cell>27 (3.8)</cell><cell>NS</cell><cell>2.3 (0.8-7.0) 2</cell><cell>0.135</cell></row><row><cell>Major bleeding</cell><cell>20 (2.1)</cell><cell>1 (0.4)</cell><cell>24 (3.4)</cell><cell>P &lt; 0.05</cell><cell>10.2 (1.3-80.3) 2</cell><cell>0.028</cell></row><row><cell>Lead dislodgement</cell><cell>25 (2.6)</cell><cell>6 (2.4)</cell><cell>19 (2.7)</cell><cell>NS</cell><cell>1.2 (0.4-3.3)</cell><cell>0.794</cell></row><row><cell>Acute renal failure</cell><cell>15 (1.6)</cell><cell>6 (2.4)</cell><cell>9 (1.3)</cell><cell>NS</cell><cell>0.5 (0.1-1.5)</cell><cell>0.187</cell></row><row><cell>Pericardial effusion</cell><cell>11 (1.1)</cell><cell>2 (0.8)</cell><cell>9 (1.3)</cell><cell>NS</cell><cell>1.7 (0.3-8.9)</cell><cell>0.499</cell></row><row><cell>Anesthesia-related</cell><cell>11 (1.1)</cell><cell>1 (0.4)</cell><cell>10 (1.4)</cell><cell>NS</cell><cell>4.0 (0.5-32.0)</cell><cell>0.197</cell></row><row><cell>complications</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Pneumothorax</cell><cell>13 (1.5)</cell><cell>0 (0)</cell><cell>13 (1.8)</cell><cell>P &lt; 0.05</cell><cell>NA 3</cell><cell></cell></row><row><cell>Wound-healing</cell><cell>7 (0.7)</cell><cell>1 (0.4)</cell><cell>6 (0.8)</cell><cell>NS</cell><cell>1.7 (0.4-15.5) 4</cell><cell>0.656</cell></row><row><cell>disorders</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Device infections</cell><cell>6 (0.6)</cell><cell>1 (0.4)</cell><cell>5 (0.7)</cell><cell>NS</cell><cell>1.3 (0.1-13.5) 4</cell><cell>0.808</cell></row><row><cell>Hemothorax</cell><cell>2 (0.2)</cell><cell>0 (0)</cell><cell>2 (0.3)</cell><cell>NS</cell><cell>NA 3</cell><cell></cell></row><row><cell>Subclavian vein</cell><cell>2 (0.2)</cell><cell>0 (0)</cell><cell>2 (0.3)</cell><cell>NS</cell><cell>NA 3</cell><cell></cell></row><row><cell>thrombosis</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Any major complication</cell><cell>73 (7.6)</cell><cell>11 (4.4)</cell><cell>62 (8.7)</cell><cell>P &lt; 0.05</cell><cell>2.1 (1.0-4.4) 5</cell><cell>0.047</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>TABLE 4</head><label>4</label><figDesc><div><p><s>Fluoroscopy data</s></p></div></figDesc><table /><note><p><s>Total, N = 880 Obese Patients, n = 230 Nonobese Patients, n = 650 Significance Fluoroscopy duration, min/sec N; mean AE SD 878; 13/58 AE 16/00 230; 14/44 AE 15/50 648; 13/42 AE 16/04 NS DAP, cGcm 2 N; mean AE SD 867; 3048 AE 5348 230; 4013 AE 5417 637; 2699 AE 5284 &lt;0.005 Abbreviations: DAP, dose-area product; NS, not significant; SD, standard deviation.</s></p></note></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>coronary artery bypass surgery, where fewer postoperative bleedings occurred in obese patients. <ref type="bibr" target="#b15">16</ref></s><s>ese patients are known to have increased levels of procoagulant factors and decreased fibrinolytic activity. <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b17">18</ref></s><s>Additionally, there may be a tendency of underdosage of anticoagulants in these patients.</s></p><p><s>We can only hypothesize if similar effects lead to the observations made in our study.</s><s>An alternative theory is that hematomas may be concealed and more distributed in overweight patients.</s><s>They may less likely cause tension on the surrounding tissue and sutures, and thus not require re-intervention as often as in lower-weight patients.</s><s>Despite these findings, CIED implantation in obese patients is not without negative implications.</s><s>Although procedure and fluoroscopy times were not prolonged, the procedures were characterized by significantly higher radiation doses, measured as DAP.</s><s>Therefore, strategies to reduce patient dose while preserving acceptable image quality are especially needed in this patient group.</s><s>Those strategies should include fluoroscopy frame rate reduction (to 2-4 frames per second), avoidance of unnecessary cine loops, asymmetric collimation, and image integration.</s><s>Additionally "low dose" programs with optimized exposure system settings and image processing can be established in cooperation with the equipment manufacturers. <ref type="bibr" target="#b18">19</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1">| Study limitations</head><p><s>This study has some important limitations.</s><s>It is a retrospective singlecenter study performed in a teaching hospital, and the drawn conclusions may not be applicable to other institutions.</s><s>Second, patients were followed up only for 6 weeks after implantation; therefore, differences between the studied groups regarding long-term complications such as infections or lead dislodgements may have been missed.</s></p><p><s>The event rates, especially in some of the distinct complication subtypes, are relatively low.</s><s>Because of this, the calculated ORs for those complication subtypes must be evaluated with caution.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5">| CONCLUSION</head><p><s>Success rates of CIED implantations were not significantly different in obese patients, whereas the number of acute major complications was significantly reduced.</s><s>CIED implantation can be safely and effectively achieved in patients with a BMI &gt;30 kg/m 2 , and obesity might even be a protective factor.</s><s>However, total radiation dose used for CIED implantation was significantly higher in the obese patient group, which emphasizes that all efforts should be made to reduce radiation exposure in these patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflicts of interest</head><p><s>The authors declare no potential conflicts of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
		<ptr target="http://www.who.int/mediacentre/factsheets/fs311/en" />
	</analytic>
	<monogr>
		<title level="j">World Health Organization. Obesity and Overweight. Fact sheet</title>
		<imprint>
			<biblScope unit="issue">311</biblScope>
			<date type="published" when="2016-06">June 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Lavie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">V</forename><surname>Milani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">O</forename><surname>Ventura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="1925" to="1932" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity</title>
		<author>
			<persName><forename type="first">R</forename><surname>Mahajan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Brooks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="1" to="11" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Obesity begets atrial fibrillation: a contemporary summary</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Magnani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Hylek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Apovi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="401" to="405" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Perioperative management of the obese surgical patient 2015: Association of Anaesthetists of Great Britain and Ireland Society for Obesity and Bariatric Anaesthesia</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Nightingale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Margarson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Shearer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anaesthesia</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="859" to="876" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Pneumothorax as a complication of central venous catheter insertion</title>
		<author>
			<persName><forename type="first">N</forename><surname>Tsotsolis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tsirgogianni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kioumis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Transl Med</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">40</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Imaging obese patients: problems and solutions</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Carucci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Abdom Imaging</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="630" to="646" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Brignole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Auricchio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Baron-Esquivias</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="2281" to="2329" />
			<date type="published" when="2013">2013. 2013</date>
		</imprint>
	</monogr>
	<note>Developed in collaboration with the European Heart Rhythm Association (EHRA)</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Comparison of ICD implantation in obese and nonobese</title>
		<author>
			<persName><forename type="first">G</forename><surname>Venkataraman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mathur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Joshi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pacing Clin Electrophysiol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="481" to="485" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Varosy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Heart Assoc</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">e003863</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Prospective study to develop surface landmarks for blind axillary vein puncture for permanent pacemaker and defibrillator lead implantation and compare it to available contrast venography guided technique</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mehrotra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Rohit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Indian Heart J</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="136" to="140" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Pneumothorax in cardiac pacing: a population-based cohort study of 28 860 Danish patients</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Kirkfeldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Johansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Nohr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Europace</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1132" to="1138" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Kirkfeldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Johansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Nohr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1186" to="1194" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference?</title>
		<author>
			<persName><forename type="first">C</forename><surname>Delhaye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wakabayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Maluenda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="1139" to="1146" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gruberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Weissman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Waksman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="578" to="584" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Northern New England Cardiovascular Disease Study Group. Obesity and risk of adverse outcomes associated with coronary artery bypass surgery</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Birkmeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Charlesworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hernandez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="1689" to="1694" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Associations of haemostatic variables with body mass index: a community-based study</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Bowles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Howarth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Coagul Fibrinolysis</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="569" to="573" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1</title>
		<author>
			<persName><forename type="first">K</forename><surname>Landin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Stigendal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Eriksson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Metabolism</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="1044" to="1048" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Safety and efficacy of applying a low-dose radiation fluoroscopy protocol in device implantations</title>
		<author>
			<persName><forename type="first">P</forename><surname>Attanasio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mirdamadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Wielandts</surname></persName>
		</author>
		<idno type="DOI">10.1002/clc.22650</idno>
		<ptr target="https://doi.org/10.1002/clc.22650" />
	</analytic>
	<monogr>
		<title level="j">Clin Cardiol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="230" to="234" />
			<date type="published" when="2016">2016. 2017</date>
		</imprint>
	</monogr>
	<note>Europace</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
